CDK4/6 Plus Aromatase Inhibitor-Induced Alopecia in Breast Cancer Patients
May 2019
in “
Journal of Clinical Oncology
”
Studysummary This study found that cyclin-dependent kinase 4/6 inhibitors used for metastatic breast cancer caused alopecia resembling androgenetic alopecia, negatively impacting patients' quality of life, but topical minoxidil showed potential for improvement.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on ascopubs.org →